CG
CROCKER GARY L Dirigeant
Other M
US US · SEC (Form 4)
€436,709
▲ Purchases (28 ops.)
Explore the complete record of transactions filed by CROCKER GARY L, Dirigeant. Insider active across 1 companies, notably Merrimack Pharmaceuticals INC. Aggregated, 28 filings have been published. Total volume traded: €437k. The latest transaction was disclosed on 9 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations 28 total
€21,582 4,452 shares @ €4.8476 4.9% of flow
Common Stock
SEC:0000899243-22-022153:0 · 9 Jun 2022
Ideal exit: 6 Mar 2023 (T+270) €1,416 300 shares @ €4.7202 0.3% of flow
Common Stock
SEC:0000899243-22-021612:0 · 7 Jun 2022
Ideal exit: 4 Mar 2023 (T+270) €11,006 2,323 shares @ €4.7379 2.5% of flow
Common Stock
SEC:0000899243-22-019682:0 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) €2,441 512 shares @ €4.7668 0.6% of flow
Common Stock
SEC:0000899243-22-019200:0 · 19 May 2022
Ideal exit: 13 Feb 2023 (T+270) €1,087 225 shares @ €4.8309 0.2% of flow
Common Stock
SEC:0000899243-22-018778:0 · 17 May 2022
Ideal exit: 11 Feb 2023 (T+270) €12,001 2,471 shares @ €4.8566 2.7% of flow
Common Stock
SEC:0000899243-22-018126:0 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) €27,689 5,000 shares @ €5.5377 6.3% of flow
Common Stock
SEC:0000899243-22-015556:0 · 21 Apr 2022
Ideal exit: 16 Jan 2023 (T+270) €894 161 shares @ €5.5546 0.2% of flow
Common Stock
SEC:0000899243-22-013091:0 · 30 Mar 2022
Ideal exit: 25 Dec 2022 (T+270) €28,035 5,000 shares @ €5.607 6.4% of flow
Common Stock
SEC:0000899243-22-012692:0 · 28 Mar 2022
Ideal exit: 23 Dec 2022 (T+270) €2,220 400 shares @ €5.5493 0.5% of flow
Common Stock
SEC:0000899243-22-012077:0 · 22 Mar 2022
Ideal exit: 17 Dec 2022 (T+270) €26,094 4,649 shares @ €5.6129 6.0% of flow
Common Stock
SEC:0000899243-22-011381:0 · 15 Mar 2022
Ideal exit: 10 Dec 2022 (T+270) €27,607 5,000 shares @ €5.5215 6.3% of flow
Common Stock
SEC:0000899243-22-011037:0 · 11 Mar 2022
Ideal exit: 6 Dec 2022 (T+270) €17,569 3,351 shares @ €5.2429 4.0% of flow
Common Stock
SEC:0000899243-22-007378:0 · 18 Feb 2022
Ideal exit: 15 Nov 2022 (T+270) €43,350 7,945 shares @ €5.4562 9.9% of flow
Common Stock
SEC:0000899243-22-007005:0 · 16 Feb 2022
Ideal exit: 13 Nov 2022 (T+270) €43,350 7,945 shares @ €5.4562 35.0% of flow
Common Stock
SEC:0000899243-22-007005 · 16 Feb 2022
Ideal exit: 13 Nov 2022 (T+270) €9,436 1,800 shares @ €5.242 2.2% of flow
Common Stock
SEC:0000899243-22-006627:0 · 14 Feb 2022
Ideal exit: 11 Nov 2022 (T+270) €2,753 673 shares @ €4.0912 0.6% of flow
Common Stock
SEC:0000899243-22-003632:0 · 27 Jan 2022
Ideal exit: 24 Oct 2022 (T+270) €2,753 673 shares @ €4.0912 2.2% of flow
Common Stock
SEC:0000899243-22-003632 · 27 Jan 2022
Ideal exit: 24 Oct 2022 (T+270) €12,492 3,100 shares @ €4.0295 10.1% of flow
Common Stock
SEC:0000899243-22-003422 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €12,492 3,100 shares @ €4.0295 2.9% of flow
Common Stock
SEC:0000899243-22-003422:0 · 26 Jan 2022
Ideal exit: 23 Oct 2022 (T+270) €8,229 2,000 shares @ €4.1143 6.6% of flow
Common Stock
SEC:0000899243-22-003136 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €8,229 2,000 shares @ €4.1143 1.9% of flow
Common Stock
SEC:0000899243-22-003136:0 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €19,885 5,000 shares @ €3.9769 16.1% of flow
Common Stock
SEC:0000899243-22-002634 · 18 Jan 2022
Ideal exit: 15 Oct 2022 (T+270) €19,885 5,000 shares @ €3.9769 4.6% of flow
Common Stock
SEC:0000899243-22-002634:0 · 18 Jan 2022
Ideal exit: 15 Oct 2022 (T+270) €19,333 5,000 shares @ €3.8667 15.6% of flow
Common Stock
SEC:0000899243-22-002118 · 13 Jan 2022
Ideal exit: 10 Oct 2022 (T+270) 25 of 28 declarations
Load more (3 remaining) About CROCKER GARY L Gary L. Crocker is an insider at Merrimack Pharmaceuticals Inc.